Emergence Therapeutics raises €87 million Series A financing to advance Nectin-4 ADC — Hadean Ventures…
Continue Reading-
Hadean Ventures Announces the 1st Closing of EUR 90m for its Second Fund
Hadean Ventures Announces the 1st Closing of EUR 90m for its Second Fund...
Continue Reading -
Cardior raises €64 M Series B to advance clinical pipeline of RNA therapeutics to treat Cardiac Disease
Cardior raises €64 M Series B to advance clinical pipeline of RNA therapeutics to treat…
Continue Reading -
Attgeno appoints Björn Westberg as CFO
Attgeno appoints Björn Westberg as CFO — Hadean Ventures Home Portfolio Team Impact Investors News…
Continue Reading -
SAGA Diagnostics raises €10.5 million
SAGA Diagnostics raises SEK 106 million (€10.5 million)...
Continue Reading -
Oncoinvent Secures NOK 250 M in an oversubscribed Pre-IPO Funding Round
Oncoinvent Secures NOK 250 M in an oversubscribed Pre-IPO Funding Round — Hadean Ventures Home…
Continue Reading -
Gesynta Pharma announces significant progress across development program for first-in-class drug candidate GS-248
Gesynta Pharma announces significant progress across development program for first-in-class drug candidate GS-248 — Hadean…
Continue Reading -
Abliva reports positive clinical Phase 1a/b results for KL1333 including signs of efficacy in PMD patients
Abliva reports positive clinical Phase 1a/b results for KL1333 including signs of efficacy in PMD…
Continue Reading -
Join Hadean Ventures!
Join Hadean Ventures! — Hadean Ventures Home Portfolio Team Impact Investors News Events Careers Contact…
Continue Reading -
Safety Monitoring Committee Approves 7 MBq as Recommended Clinical Dose for Radspherin®
Safety Monitoring Committee Approves 7 MBq as Recommended Clinical Dose for Radspherin® — Hadean Ventures…
Continue Reading